MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
Saved in:
| Title: | MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis. |
|---|---|
| Authors: | Spec, Andrej1 (AUTHOR) andrejspec@wustl.edu, Pullman, John2 (AUTHOR), Thompson, George R3 (AUTHOR), Powderly, William G1 (AUTHOR), Tobin, Ellis H4 (AUTHOR), Vazquez, Jose5 (AUTHOR), Wring, Stephen A6 (AUTHOR), Angulo, David6 (AUTHOR), Helou, Silvia6 (AUTHOR), Pappas, Peter G7 (AUTHOR), Group, Mycoses Study (AUTHOR), Mycoses Study Group (CORPORATE AUTHOR) |
| Source: | Journal of Antimicrobial Chemotherapy (JAC). Oct2019, Vol. 74 Issue 10, p3056-3062. 7p. |
| Database: | Environment Complete |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: eih DbLabel: Environment Complete An: 138760358 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Spec%2C+Andrej%22">Spec, Andrej</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> andrejspec@wustl.edu</i><br /><searchLink fieldCode="AR" term="%22Pullman%2C+John%22">Pullman, John</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thompson%2C+George+R%22">Thompson, George R</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powderly%2C+William+G%22">Powderly, William G</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tobin%2C+Ellis+H%22">Tobin, Ellis H</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vazquez%2C+Jose%22">Vazquez, Jose</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wring%2C+Stephen+A%22">Wring, Stephen A</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Angulo%2C+David%22">Angulo, David</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Helou%2C+Silvia%22">Helou, Silvia</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pappas%2C+Peter+G%22">Pappas, Peter G</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Group%2C+Mycoses+Study%22">Group, Mycoses Study</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mycoses+Study+Group%22">Mycoses Study Group</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Antimicrobial+Chemotherapy+%28JAC%29%22">Journal of Antimicrobial Chemotherapy (JAC)</searchLink>. Oct2019, Vol. 74 Issue 10, p3056-3062. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=eih&AN=138760358 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jac/dkz277 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 3056 Titles: – TitleFull: MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spec, Andrej – PersonEntity: Name: NameFull: Pullman, John – PersonEntity: Name: NameFull: Thompson, George R – PersonEntity: Name: NameFull: Powderly, William G – PersonEntity: Name: NameFull: Tobin, Ellis H – PersonEntity: Name: NameFull: Vazquez, Jose – PersonEntity: Name: NameFull: Wring, Stephen A – PersonEntity: Name: NameFull: Angulo, David – PersonEntity: Name: NameFull: Helou, Silvia – PersonEntity: Name: NameFull: Pappas, Peter G – PersonEntity: Name: NameFull: Group, Mycoses Study – PersonEntity: Name: NameFull: Mycoses Study Group IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 03057453 Numbering: – Type: volume Value: 74 – Type: issue Value: 10 Titles: – TitleFull: Journal of Antimicrobial Chemotherapy (JAC) Type: main |
| ResultId | 1 |